In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 24th, 2005 | 36 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.21 | -2.72 | -50.46 | 4 | 8 | 1 | 96 | 533.528 | 11 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 390 | 0.25 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 48 | 0.28 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 48 | 0.28 | Binding ≤ 10μM |
FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 48 | 0.28 | Binding ≤ 10μM |
FGFR4-1-E | Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 48 | 0.28 | Binding ≤ 10μM |
MK01-1-E | Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.22 | Binding ≤ 10μM |
MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2800 | 0.22 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 360 | 0.25 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 450 | 0.25 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 44 | 0.29 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 450 | 0.25 | Functional ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 450 | 0.25 | Functional ≤ 10μM |
Z80166-4-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other | Other | 900 | 0.24 | Functional ≤ 10μM |
Z80742-1-O | C6 (Glioma Cells) (cluster #1 Of 3), Other | Other | 5800 | 0.20 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 240 | 0.26 | Binding ≤ 1μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 48 | 0.28 | Binding ≤ 1μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 48 | 0.28 | Binding ≤ 1μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 48 | 0.28 | Binding ≤ 1μM |
FGFR4_HUMAN | P22455 | Fibroblast Growth Factor Receptor 4, Human | 48 | 0.28 | Binding ≤ 1μM |
PGFRA_MOUSE | P26618 | Platelet-derived Growth Factor Receptor Alpha, Mouse | 360 | 0.25 | Binding ≤ 1μM |
PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 310 | 0.25 | Binding ≤ 1μM |
PGFRB_MOUSE | P05622 | Platelet-derived Growth Factor Receptor Beta, Mouse | 360 | 0.25 | Binding ≤ 1μM |
PGFRB_RAT | Q05030 | Platelet-derived Growth Factor Receptor Beta, Rat | 310 | 0.25 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 44 | 0.29 | Binding ≤ 1μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 23 | 0.30 | Binding ≤ 1μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 2800 | 0.22 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 240 | 0.26 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 48 | 0.28 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 48 | 0.28 | Binding ≤ 10μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 48 | 0.28 | Binding ≤ 10μM |
FGFR4_HUMAN | P22455 | Fibroblast Growth Factor Receptor 4, Human | 48 | 0.28 | Binding ≤ 10μM |
MK01_HUMAN | P28482 | MAP Kinase ERK2, Human | 2800 | 0.22 | Binding ≤ 10μM |
PGFRA_MOUSE | P26618 | Platelet-derived Growth Factor Receptor Alpha, Mouse | 360 | 0.25 | Binding ≤ 10μM |
PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 310 | 0.25 | Binding ≤ 10μM |
PGFRB_MOUSE | P05622 | Platelet-derived Growth Factor Receptor Beta, Mouse | 360 | 0.25 | Binding ≤ 10μM |
PGFRB_RAT | Q05030 | Platelet-derived Growth Factor Receptor Beta, Rat | 310 | 0.25 | Binding ≤ 10μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 23 | 0.30 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 44 | 0.29 | Binding ≤ 10μM |
Z80742 | Z80742 | C6 (Glioma Cells) | 5800 | 0.20 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 900 | 0.24 | Functional ≤ 10μM |
PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 450 | 0.25 | Functional ≤ 10μM |
PGFRB_RAT | Q05030 | Platelet-derived Growth Factor Receptor Beta, Rat | 450 | 0.25 | Functional ≤ 10μM |
Description | Species |
---|---|
Activated point mutants of FGFR2 | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
Advanced glycosylation endproduct receptor signaling | |
betaKlotho-mediated ligand binding | |
c-src mediated regulation of Cx43 function and closure of gap junctions | |
CD28 co-stimulation | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Ras | |
CTLA4 inhibitory signaling | |
DCC mediated attractive signaling | |
Downstream signal transduction | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK1 activation | |
ERK2 activation | |
ERKs are inactivated | |
FCERI mediated MAPK activation | |
FGFR4 ligand binding and activation | |
FRS2-mediated cascade | |
GAB1 signalosome | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GP1b-IX-V activation signalling | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Growth hormone receptor signaling | |
Integrin alphaIIb beta3 signaling | |
Interleukin-1 signaling | |
MEK activation | |
NCAM signaling for neurite out-growth | |
Negative regulation of FGFR signaling | |
Netrin mediated repulsion signals | |
Oncogene Induced Senescence | |
Oxidative Stress Induced Senescence | |
p130Cas linkage to MAPK signaling for integrins | |
p38MAPK events | |
phospho-PLA2 pathway | |
Phospholipase C-mediated cascade | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
RAF phosphorylates MEK | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of HSF1-mediated heat shock response | |
Regulation of KIT signaling | |
RSK activation | |
Senescence-Associated Secretory Phenotype (SASP) | |
SHC-mediated cascade | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal attenuation | |
Signal regulatory protein (SIRP) family interactions | |
Signal transduction by L1 | |
Signaling by activated point mutants of FGFR1 | |
Signaling by activated point mutants of FGFR3 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by FGFR3 mutants | |
Signaling by FGFR4 mutants | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
t(4;14) translocations of FGFR3 | |
Thrombin signalling through proteinase activated receptors (PARs) | |
Uptake and function of anthrax toxins | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.